AK
Anil Kumar
About Anil Kumar
Data last updated:
Anil Kumar has 15 years in corporate governance. Holds Director and Ceo roles. Currently with 4 companies, including Airamatrix Private Limited and Sun Pharma Advanced Research Company Limited. Formerly with 4 companies, such as Quintiles Phase One Clinical Trials India Private Limited and Iqvia Rds (India) Private Limited. Engaged in General Business, Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹107 Cr; the largest is Sun Pharma Advanced Research Company Limited at ₹73.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharma Advanced Research Company Limited L73100GJ2006PLC047837 | Ceo | 25 May 2021 | 2006 | ₹73.56 Cr (FY 2025) | Active |
 Airamatrix Private Limited U72100MH2020PTC338495 | Director | 02 Mar 2020 | 2020 | ₹33.57 Cr (FY 2025) | Active |
 Neaube Advisory Services Llp ACR-8063 | Designated Partner | 03 Oct 2025 | 2025 | – | Active |
| Genokine Biotech Limited U21000GJ2025PLC164880 | Director | 04 Jul 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Quintiles Phase One Clinical Trials India Private Limited U73100TG2009FTC064239 | Director | 16 Jun 2011 | 2009 | ₹4.16 Cr (FY 2020) | Dissolved (Liquidated) |
 Iqvia Rds (India) Private Limited U74909KA2002PTC107115 | Managing Director | 10 Jun 2011 | 2002 | ₹3,342 Cr (FY 2025) | Active |
| Quintiles Technologies (India) Private Limited U73100GJ2002PTC041630 | Director | 25 Jul 2011 | 2002 | – | Amalgamated |
 Quintiles Data Processing Centre (India) Private Limited U72300GJ2001PTC040151 | Director | 21 Sep 2011 | 2001 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar
Anil Kumar has 15 years in corporate governance. Holds Director and Ceo roles. Currently with 4 companies, including Airamatrix Private Limited and Sun Pharma Advanced Research Company Limited. Formerly with 4 companies, such as Quintiles Phase One Clinical Trials India Private Limited and Iqvia Rds (India) Private Limited. Engaged in General Business, Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹107 Cr; the largest is Sun Pharma Advanced Research Company Limited at ₹73.56 Cr (FY 2025).
Anil Kumar is associated with 4 companies as Director and Ceo, including Sun Pharma Advanced Research Company Limited (₹73.56 Cr), Airamatrix Private Limited (₹33.57 Cr), Neaube Advisory Services Llp.
Anil Kumar has expertise in General Business, Technology.
Anil Kumar has 15 years in corporate governance.
By reported revenue, the largest current company of Anil Kumar is Sun Pharma Advanced Research Company Limited, with revenue of ₹73.56 Cr (FY 2025).
The 2 current companies of Anil Kumar that report revenue have a combined latest revenue of ₹107 Cr.
Anil Kumar currently holds positions at 4 companies: Sun Pharma Advanced Research Company Limited (₹73.56 Cr), Airamatrix Private Limited (₹33.57 Cr), Neaube Advisory Services Llp, Genokine Biotech Limited.